Diokno AC, Brock BM, Brown MB, et al.: Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 1986, 136:1022–1025.PubMed
Nygaard I, Barber MD, Burgio KL, et al.: Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008, 300:1311–1316.CrossRefPubMed
Thom DH, Nygaard IE, Calhoun EA: Urologic diseases in America project: urinary incontinence in women-national trends in hospitalizations, office visits, treatment and economic impact. J Urol 2005, 173:1295–1301.CrossRefPubMed
Hu TW, Wagner TH, Bentkover JD, et al.: Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 2004, 63:461–465.CrossRefPubMed
• Subak LL, Brubaker L, Chai TC, et al.: High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet Gynecol 2008, 111:899–907. This recent study highlights the economic costs associated with SUI, a factor to which we as practitioners will need to increasingly pay attention.
Stothers L, Thom D, Calhoun E: Urologic diseases in America project: urinary incontinence in males—demographics and economic burden. J Urol 2005, 173:1302–1308.CrossRefPubMed
Payne C: Conservative management of urinary incontinence: behavioral and pelvic floor therapy, urethral and pelvic devices. In Campbell-Walsh Urology. Edited by Wein AJ, Novick AC, Partin AW, Peters CA. Philadelphia, PA: Saunders Elsevier; 2007:2124–2146.
Roe B, Milne J, Ostaszkiewicz J, et al.: Systematic reviews of bladder training and voiding programmes in adults: a synopsis of findings on theory and methods using metastudy techniques. J Adv Nurs 2007, 57:3–14.CrossRefPubMed
Elder DD, Stephenson TP: An assessment of the Frewen regime in the treatment of detrusor dysfunction in females. Br J Urol 1980, 52:467–471.CrossRefPubMed
Fantl JA, Wyman JF, McClish DK, et al.: Efficacy of bladder training in older women with urinary incontinence. JAMA 1991, 265:609–613.CrossRefPubMed
Ostaszkiewicz J, Johnston L, Roe B: Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev 2004, 1:CD002802.
Dallosso HM, McGrother CW, Matthews RJ, et al.: The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003, 92:69–77.CrossRefPubMed
Dallosso HM, Matthews RJ, McGrother CW, et al.: The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men. Public Health Nutr 2004, 7:885–891.CrossRefPubMed
Smith JH, Berghmans B, Burgio K, et al.: Adult conservative management. In Incontinence. Edited by Abrams P, Cardoza L, Khoury S, Wein A. Paris, France: Health Publications Ltd.; 2009:1027–1120.
Tomlinson BU, Dougherty MC, Pendergast JF, et al.: Dietary caffeine, fluid intake and urinary incontinence in older rural women. Int Urogynecol J Pelvic Floor Dysfunct 1999, 10:22–28.CrossRefPubMed
Arya LA, Myers DL, Jackson ND: Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol 2000, 96:85–89.CrossRefPubMed
Swithinbank L, Hashim H, Abrams P: The effect of fluid intake on urinary symptoms in women. J Urol 2005, 174:187–189.CrossRefPubMed
Dowd TT, Campbell JM, Jones JA: Fluid intake and urinary incontinence in older community-dwelling women. J Community Health Nurs 1996, 13:179–186.CrossRefPubMed
Subak LL, Richter HE, Hunskaar S: Obesity and urinary incontinence: epidemiology and clinical research update. J Urol 2009, 182(6 Suppl):S2–S7.CrossRefPubMed
• Shamliyan TA, Kane RL, Wyman J, et al.: Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008, 148:459–473. This is a thorough review of randomized controlled trials conducted to measure the effectiveness of all conservative treatment modalities.
• Dumoulin C, Hay-Smith J: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2010, 1:CD005654. This article highlights the value of PFMT in the conservative management of UI. This area is ripe for the standardization of training protocols so that better data regarding treatment effectiveness can be ascertained.
Weatherall M: Biofeedback in urinary incontinence: past, present and future. Curr Opin Obstet Gynecol 2000, 12:411–413.CrossRefPubMed
But I: Conservative treatment of female urinary incontinence with functional magnetic stimulation. Urology 2003, 61:558–561.CrossRefPubMed
Fujishiro T, Enomoto H, Ugawa Y, et al.: Magnetic stimulation of the sacral roots for the treatment of stress incontinence: an investigational study and placebo controlled trial. J Urol 2000, 164:1277–1279.CrossRefPubMed
Amaro JL, Gameiro MO, Kawano PR, et al.: Intravaginal electrical stimulation: a randomized, double-blind study on the treatment of mixed urinary incontinence. Acta Obstet Gynecol Scand 2006, 85:619–622.CrossRefPubMed
Nygaard I: Prevention of exercise incontinence with mechanical devices. J Reprod Med 1995, 40:89–94.PubMed
Davila GW, Kondo A: Introl bladder neck support prosthesis: international clinical experience. Int Urogynecol J Pelvic Floor Dysfunct 1997, 8:301–306.CrossRefPubMed
Sirls LT, Foote JE, Kaufman JM, et al.: Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2002, 13:88–95; discussion 95.CrossRefPubMed
Nabi G, Cody JD, Ellis G, et al.: Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006, 4:CD003781.
Alhasso A, Glazener CM, Pickard R, et al.: Adrenergic drugs for urinary incontinence in adults. Cochrane Database Syst Rev 2005, 3:CD001842.
Mariappan P, Ballantyne Z, N’Dow JM, et al.: Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev 2005, 3:CD004742.
Hendrix SL, Cochrane BB, Nygaard IE, et al.: Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005, 293:935–948.CrossRefPubMed
Akhila V, Pratapkumar: A comparison of transdermal and oral HRT for menopausal symptom control. Int J Fertil Womens Med 2006, 51:64–69.PubMed
Cody JD, Richardson K, Moehrer B, et al.: Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2009, 4:CD001405.
• Farrell SA, Scott TA, Farrell KA, et al.: Two models for delivery of women’s continence care: the step-wise continence team versus the traditional medical model. J Obstet Gynaecol Can 2009, 31:247–253. We like the novel approach of treatment delivery highlighted in this article. It will be incumbent upon physicians to help lead the way in the development of new treatment delivery systems in the future.